DOC: EPIDEMIOLOGY AND PREVENTION OF HEPATITIS B VIRUS INFECTION


Hepatitis B is one of the most common infectious diseases globally. It has been estimated that there are 350 million chronic hepatitis B virus (HBV) carriers worldwide. The prevalence of chronic HBV infection varies geographically, from high (>8%), intermediate (2-7%) to low (<2%) prevalence.... Document/File: .pdf, filesize: n/a. Filetype: pdf. Filename: epidemiology-and-prevention-of-hepatitis-b-virus-infection. Title: Epidemiology and Prevention of Hepatitis B Virus Infection. 2014.

 

File Info:

  • Filesize: N/A
  • Source: medsci_dot_org
  •   Date Archived: 2017-05-28
  •   Author: N/A
 
 
 
 
 

Related Files:

 

  HEPATITIS B VIRUS: EPIDEMIOLOGY AND TRANSMISSION RISKS

... HEPATITIS B VIRUS (HBV) INFECTION IS A SERIOUS AND COMMON INFECTIOUS DISEASE OF THE LIVER, AFFECTING MILLIONS OF PEOPLE THROUGHOUT THE WORLD. THE INCUBATION PERIOD FOR HBV IS 45-180 DAYS, MOST COMMONLY 60-90 DAYS. ...
  hepatitis-b-virus-epidemiology-and-transmission-risks     PDF     2017-05-28  
 

 

  HEPATITIS B IMMUNE GLOBULIN

... PREVENTS HEPATITIS B INFECTION INPATIENTS WHO ARE KNOWN TO HAVE BEEN EXPOSED, INCLUDING NEONATES BORN TO HBSAG-POSITIVE WOMEN, BY PROVIDING PASSIVE IMMUNITY. ACTION AN IMMUNE GAMMA-GLOBULIN FRACTION CONTAINING HIGH TITERS OF ANTIBODIES TO THE HEPATITIS B SURFACE ANTIGEN. CONFERS PASSIVE IMMUNITY TO HEPATITIS B INFECTION. THERAPEUTIC EFFECTS: PREVENTION OF HEPATITIS B INFECTION. ...
  hepatitis-b-immune-globulin     PDF     2017-05-27  
 

 

  CLINICAL GUIDELINES ON THE MANAGEMENT OF HEPATITIS C

... PATIENTS INFECTED WITH HEPATITIS C VIRUS (HCV) SHOULD BE REFERRED TO A CLINICIAN WITH A PARTICULAR INTEREST IN THE INFECTION. PATIENTS MUST HAVE ACCESS TO ADEQUATE COUNSELLING FROM A HEALTH CARER WITH KNOWLEDGE AND EXPERIENCE OF CHRONIC HCV INFECTION. ALL PATIENTS MUST HAVE ACCESS TO THE APPROPRIATE DIAGNOSTIC AND THERAPEUTIC OPTIONS AVAILABLE IN THE MANAGEMENT OF HCV INFECTION. ...
  clinical-guidelines-on-the-management-of-hepatitis-c     PDF     2017-05-27  
 

 

  HEPATITIS B VIRUS REPLICATION AND INTEGRATION

... CHRONIC INFECTION WITH HEPATITIS B VIRUS (HBV) AFFECTS 240 MILLION PEOPLE WORLDWIDE AND MAY CAUSE LIVER DISEASE INCLUDING HEPATOCELLULAR CARCINOMA (HCC). INITIALLY PATIENTS HAVE HIGH LEVELS OF HBV DNA IN THEIR BLOOD, NO LIVER DISEASE AND EXPRESS THE E ANTIGEN (HBEAG). ...
  hepatitis-b-virus-replication-and-integration     PDF     2017-05-28  
 

 

  HEPATITIS B VIRUS BIOLOGY

... HEPATITIS B VIRUS (HBV) CAUSES TRANSIENT AND CHRONIC INFECTIONS OF THE LIVER. TRANSIENT INFECTIONS MAY PRODUCE SERIOUS ILLNESS, AND APPROXIMATELY 0.5% TERMINATE WITH FATAL, FULMINANT HEPATITIS. CHRONIC INFECTIONS MAY ALSO HAVE SERIOUS CONSEQUENCES: NEARLY 25% TERMINATE IN UNTREATABLE LIVER CANCER (10). WORLDWIDE DEATHS FROM LIVER CANCER CAUSED BY HBV INFECTION PROBABLY EXCEED ONE MILLION PER YEAR (52, 162). ...
  hepatitis-b-virus-biology     PDF     2017-05-28  
 

 

  RELAPSE PREVENTION AND THE FIVE RULES OF RECOVERY

... RELAPSE PREVENTION IS WHY MOST PEOPLE SEEK TREATMENT. BY THE TIME MOST INDIVIDUALS SEEK HELP, THEY HAVE ALREADY TRIED TO QUIT ON THEIR OWN AND THEY ARE LOOKING FOR A BETTER SOLUTION. THIS ARTICLE OFFERS A PRACTICAL APPROACH TO RELAPSE PREVENTION THAT WORKS WELL IN BOTH INDIVIDUAL AND GROUP THERAPY. ...
  relapse-prevention-and-the-five-rules-of-recovery     PDF     2017-05-18  
 

 

  ALUMINIUM FOIL FOR SMOKING DRUGS

... THE 2010 DRUG STRATEGY CONTAINS A C LEAR AMBITION THAT MORE DRUG USERS WILL BE SUPPORTED TO BECOME DRUG FREE. IT ALSO SUPPORTS THE CONTINUED PREVENTION OF BLOOD - BORNE VIRUS TRANSMISSION AND DRUG - RELATED DEATHS IN THOSE WHO CONTINUE TO USE DRUGS. ...
  aluminium-foil-for-smoking-drugs     PDF     2017-05-18  
 

 

  HEPATITIS B IMMUNE GLOBULIN (HUMAN)

... HEPATITIS B IMMUNE GLOBULIN (HUMAN) — HYPERHEPB® S/D TREATED WITH SOLVENT/DETERGENT IS A COLORLESS TO PALE YELLOW OR PINK STERILE SOLUTION OF HEPATITIS B HYPERIMMUNE IMMUNE GLOBULIN FOR INTRAMUSCULAR ADMINISTRATION; IT IS PRESERVATIVE-FREE AND LATEX-FRE ...
  hepatitis-b-immune-globulin-human     PDF     2017-05-27  
 

 

  A RECOMBINANT VESICULAR STOMATITIS VIRUS EBOLA VACCINE

... THE WORST EBOLA VIRUS DISEASE (EVD) OUTBREAK IN HISTORY HAS RESULTED IN MORE THAN 28,000 CASES AND 11,000 DEATHS. WE PRESENT THE FINAL RESULTS OF TWO PHASE 1 TRIALS OF AN ATTENUATED, REPLICATION-COMPETENT, RECOMBINANT VESICULAR STOMATITIS VIRUS (RVSV)–BASED VACCINE CANDIDATE DESIGNED TO PREVENT EVD. ...
  a-recombinant-vesicular-stomatitis-virus-ebola-vaccine     PDF     2017-05-28  
 

 

  CONJUNCTIVITIS ("PINK EYE") FACT SHEET

... CONJUNCTIVITIS IS AN INFECTION OF THE EYES COMMONLY KNOWN AS "PINK EYE" IT IS MOST OFTEN CAUSED BY A VIRUS BUT CAN ALSO BE CAUSED BY BACTERIA. SYMPTOMS OF THE EYE INCLUDE: - REDNESS, IRRITATION, ITCHINESS; MAY PRODUCE LOTS OF TEARS - CLEAR OR YELLOW DISCHARGE THAT MAY MAKE THE EYELIDS STICK TOGETHER, ESPECIALLY IN THE MORNING - SWELLING OF EYELIDS ...
  conjunctivitis-pink-eye-fact-sheet     PDF     2017-05-27